ArticleFrontiers in endocrinology2025
The association of obesity and lipid-related indicators with all-cause and cardiovascular mortality risks in patients with diabetes or prediabetes: a cross-sectional study based on machine learning algorithms.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Associations of triglyceride-glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis.Cardiovascular diabetology · 2026Pooled it
- Association between the triglyceride-glucose index and its correlation indices and stress urinary incontinence in American adult women: a population-based cross-sectional study.Przeglad menopauzalny = Menopause review · 2026Article
- Combining triglyceride‑glucose index and novel anthropometric measures to predict mortality risk in patients with T2DM: a prospective cohort study.BMC endocrine disorders · 2026Article
- Combination of triglyceride-glucose index and waist-to-height ratio as a predictor of all-cause and cardiovascular mortality in adults with diabetes or prediabetes: a nationwide prospective cohort study.Cardiovascular diagnosis and therapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to explore the associations between various obesity and lipid-related indicators in patients with diabetes or prediabetes. Specifically, the indicators examined include the triglyceride-glucose index (TyG), along with its derived metrics: TyG-BMI, TyG-WHtR, TyG-WWI, TyG-WC, lipid accumulation product (LAP), visceral adiposity index (VAI), and abdominal obesity index (ABSI), resulting in a total of eight indicators. Methods: This study utilizes data from the NHANES conducted from 1999 to 2018, analyzing a cohort of 4,058 patients diagnosed with diabetes/prediabetes. We utilized multivariable Cox regression models to evaluate the impact of these indicators on both all-cause and cardiovascular mortality rates. Additionally, we compared the predictive performance of eight machine learning (ML) algorithms regarding mortality risk and used the SHAP method to clarify the significance of obesity and lipid-related indicators in mortality prediction. Results: The results of the multivariable Cox regression analysis reveal significant associations between TyG, TyG-WWI, and ABSI with all-cause mortality among patients with diabetes/prediabetes. Compared to baseline levels, the HR for TyG in the fourth quartile (Q4) was 1.49, while for TyG-WWI (Q4), the HR was 1.52. Furthermore, ABSI was associated with increased all-cause mortality risk in groups Q3 and Q4, presenting risk ratios of 1.80 and 1.68, respectively. Notably, TyG (Q4) was also significantly associated with cardiovascular mortality risk, with an HR of 1.98. RCS analysis indicated a linear trend between TyG, TyG-WWI, and all-cause mortality, whereas ABSI displayed a non-linear trend. Among the ML algorithms evaluated, the XGBoost model exhibited the strongest predictive capability. The SHAP analysis indicated that the indicators with the greatest impact on all-cause mortality in patients with diabetes/prediabetes were ranked as follows: TyG > ABSI > TyG-WWI. Furthermore, sex-based subgroup analysis indicated that VAI was positively associated with cardiovascular mortality in male patients with diabetes/prediabetes, exhibiting a linear trend. Conclusion: TyG, TyG-WWI, ABSI, and VAI are closely linked to mortality risk in diabetes/prediabetes patients. Among these, TyG is significantly associated with both all-cause and cardiovascular mortality, showing superior predictive capability. We recommend long-term monitoring of these indicators and their inclusion in management strategies to effectively inform diabetes/prediabetes patients about their mortality risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.